Recent significant events relating to digital dentistry market
In May 2023, Henry Schein announced the acquisition of Brazilian company S.I.N. Implant System. The company specialises in value dental implant solutions and has been expanding into the US market. Henry Schein is planning to integrate S.I.N. into its Global Oral Reconstruction Group. The combined forces of the two companies are set to form a global supply of dental implant and bone regeneration materials to address the growing demand in both emerging and developed markets. The acquisition is expected to be completed in the second half of this year.
In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, extending the company’s dental bone grafting portfolio, primarily focusing on the North American market. Both products are processed by RTI Surgical and marketed by ZimVie
In April 2023, Medentika, a member of the Straumann Group since 2016, announced the launch of a brand awareness campaign for its MPS multiplatform portfolio of dental implants and prosthetic components. The campaign is called “This is MEDENTiKA”.
In March 2023, ZimVie introduced the CAD and FULL SUITE modules for its RealGUIDE digital dentistry software platform at the International Dental Show in Germany. The FULL SUITE integration provides a seamless workflow between the CAD module and RealGUIDE’s existing Plan, App and Guide modules, offering a one-stop solution for surgical and restorative treatment.
In February 2023, BEGO and Rapid Shape announced their partnership allowing Rapid Shape customers to process BEGO’s Varseo materials on Rapid Shape’s D20+, D30+ and D50+ printers. This allows users of those 3D printers to produce a broad range of restorative solutions with BEGO’s VarseoSmile and VarseoWax materials.
In January 2023, Nobel Biocare announced its acquisition of Mimetis Biomaterials, a spin-off from the Biomaterials, Biomechanics and Tissue Engineering group of the Polytechnic University of Catalonia in Spain. Nobel and Mimetis have partnered in the development of materials since 2016, the newest product of which is creos syntogain, the latest-generation synthetic bone grafting material developed by Mimetis. Through its partnership with Mimetis, Nobel has been able to expand its portfolio of regenerative solutions.
In its annual report for 2022, the Straumann Group announced 2023 additions to its portfolio, including value dental implant systems, abutments, grafting materials and growth factor. This included an Anthogyr line extension with the Axiom X3 tissue-level implant, the extension of the BLX and TLX implant family lines, an addition to the Variobase abutment family and the Zygoma-S implant designed for the zygoma anatomy-guided approach. The company also announced the continuous global roll-out of cerabone plus, a bovine bone grafting material with sodium hyaluronate, starting with Germany, Austria, Switzerland and the Nordic countries. The company also announced the global release of the Medentika multiplatform and implant system. Other new products are the fully tapered TLX tissue-level implant system for immediate protocols, the Neodent two-piece screw-retained zirconia–zirconia connection implant with a tapered design and the Neodent Helix GM Narrow implant, also for immediate protocols. The company is planning a continuous global roll-out of its Emdogain growth factor, featuring the latest extension of its indications to flapless surgery and peri-implant therapy.
To post a reply please login or register